The Role of Akt/protein Kinase B Subtypes in Retinal Ischemic Preconditioning

Overview

Journal Exp Eye Res

Specialty Ophthalmology

Date 2008 Dec 17

PMID 19084003

Citations 19

Authors

John C Dreixler

Jonathan W Hemmert

Shanti K Shenoy

Yang Shen

H Thomas Lee

Afzhal R Shaikh

Daniel M Rosenbaum

Steven Roth

Affiliations

Soon will be listed here.

Abstract

Potent endogenous protection from ischemia can be induced in the retina by ischemic preconditioning (IPC). Protein kinase B/Akt is a cellular survival factor. We hypothesized that Akt was integral to IPC based upon differential effects of Akt subtypes. Rats were subjected to retinal ischemia after IPC or IPC-mimicking by the opening of mitochondrial KATP (mKATP) channels. The effects of blocking Akt using wortmannin, API-2, or small interfering RNA (siRNA) were examined. Electroretinography assessed functional recovery after ischemia, and TUNEL examined retinal ganglion cell apoptosis. We studied the relationship between Akt activation and known initiators of IPC, including adenosine receptor stimulation and the opening of mKATP channels. The PI-3 kinase inhibitor wortmannin 1 or 4 mg/kg (i.p.), the specific Akt inhibitor API-2, 5-500 microM in the vitreous, or intravitreal siRNA directed against Akt2 or -3, but not Akt1, significantly attenuated the neuroprotective effect of IPC. Interfering RNA against any of the three Akt subtypes significantly but time-dependently attenuated mKATP channel opening to mimic IPC. Adenosine A1 receptor blockade (DPCPX), A2a blockade (CSC), or the mKATP channel blocker 5-hydroxydecanoic acid significantly attenuated Akt activation after IPC. Interfering RNA directed against Akt subtypes prevented the ameliorative effect of IPC on post-ischemic apoptosis. All three Akt subtypes are involved in functional retinal neuroprotection by IPC or IPC-mimicking. Akt is downstream of adenosine A1 and A2a receptors and mKATP channel opening. The results indicate the presence in the retina of robust and redundant endogenous neuroprotection based upon subtypes of Akt.

Citing Articles

Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension.

Sheng S, Ma Y, Zou Y, Hu F, Chen L Front Immunol. 2023; 13:1094132.

PMID: 36741384 PMC: 9889850. DOI: 10.3389/fimmu.2022.1094132.

Caffeine exposure ameliorates acute ischemic cell death in avian developing retina.

Pereira-Figueiredo D, Brito R, Araujo D, Nascimento A, Lyra E, Cheibub A Purinergic Signal. 2020; 16(1):41-59.

PMID: 32078115 PMC: 7166236. DOI: 10.1007/s11302-020-09687-1.

Adaptive Plasticity in the Retina: Protection Against Acute Injury and Neurodegenerative Disease by Conditioning Stimuli.

Gidday J Cond Med. 2019; 1(2):85-97.

PMID: 31423482 PMC: 6696944.

PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection.

Husain S, Ahmad A, Singh S, Peterseim C, Abdul Y, Nutaitis M Invest Ophthalmol Vis Sci. 2017; 58(14):6489-6499.

PMID: 29288267 PMC: 5749243. DOI: 10.1167/iovs.16-20673.

Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats.

Mathew B, Poston J, Dreixler J, Torres L, Lopez J, Zelkha R Graefes Arch Clin Exp Ophthalmol. 2017; 255(8):1581-1592.

PMID: 28523456 PMC: 5841582. DOI: 10.1007/s00417-017-3690-1.

References

Fukunaga K, Kawano T . Akt is a molecular target for signal transduction therapy in brain ischemic insult. J Pharmacol Sci. 2003; 92(4):317-27. DOI: 10.1254/jphs.92.317. View

Sidhu J, Liu F, Boyle S, Omiecinski C . PI3K inhibitors reverse the suppressive actions of insulin on CYP2E1 expression by activating stress-response pathways in primary rat hepatocytes. Mol Pharmacol. 2001; 59(5):1138-46. DOI: 10.1124/mol.59.5.1138. View

Jomary C, Cullen J, Jones S . Inactivation of the Akt survival pathway during photoreceptor apoptosis in the retinal degeneration mouse. Invest Ophthalmol Vis Sci. 2006; 47(4):1620-9. DOI: 10.1167/iovs.05-1176. View

Hillion J, Li Y, Maric D, Takanohashi A, Klimanis D, Barker J . Involvement of Akt in preconditioning-induced tolerance to ischemia in PC12 cells. J Cereb Blood Flow Metab. 2006; 26(10):1323-31. PMC: 1855183. DOI: 10.1038/sj.jcbfm.9600286. View

Kamphuis W, Dijk F, Bergen A . Ischemic preconditioning alters the pattern of gene expression changes in response to full retinal ischemia. Mol Vis. 2007; 13:1892-901. View

Cardone M, Roy N, Stennicke H, Salvesen G, Franke T, Stanbridge E . Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998; 282(5392):1318-21. DOI: 10.1126/science.282.5392.1318. View

Mullonkal C, Toledo-Pereyra L . Akt in ischemia and reperfusion. J Invest Surg. 2007; 20(3):195-203. DOI: 10.1080/08941930701366471. View

Parcellier A, Tintignac L, Zhuravleva E, Hemmings B . PKB and the mitochondria: AKTing on apoptosis. Cell Signal. 2007; 20(1):21-30. DOI: 10.1016/j.cellsig.2007.07.010. View

Dreixler J, Shaikh A, Shenoy S, Shen Y, Roth S . Protein kinase C subtypes and retinal ischemic preconditioning. Exp Eye Res. 2008; 87(4):300-11. PMC: 2602824. DOI: 10.1016/j.exer.2008.05.015. View

10.

Robey R, Hay N . Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene. 2006; 25(34):4683-96. DOI: 10.1038/sj.onc.1209595. View

11.

Zhang C, Rosenbaum D, Shaikh A, Li Q, Rosenbaum P, Pelham D . Ischemic preconditioning attenuates apoptotic cell death in the rat retina. Invest Ophthalmol Vis Sci. 2002; 43(9):3059-66. View

12.

Huang Y, Cen L, Luo J, Wang N, Zhang M, van Rooijen N . Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension. Neuroscience. 2008; 153(1):214-25. DOI: 10.1016/j.neuroscience.2008.02.007. View

13.

Chong Z, Li F, Maiese K . Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol. 2005; 75(3):207-46. DOI: 10.1016/j.pneurobio.2005.02.004. View

14.

Liu X, Mameza M, Lee Y, Eseonu C, Yu C, Kang Derwent J . Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells. Diabetes. 2008; 57(6):1651-8. PMC: 2756726. DOI: 10.2337/db07-1761. View

15.

Dummler B, Tschopp O, Hynx D, Yang Z, Dirnhofer S, Hemmings B . Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol. 2006; 26(21):8042-51. PMC: 1636753. DOI: 10.1128/MCB.00722-06. View

16.

Li G, Anderson R, Tomita H, Adler R, Liu X, Zack D . Nonredundant role of Akt2 for neuroprotection of rod photoreceptor cells from light-induced cell death. J Neurosci. 2007; 27(1):203-11. PMC: 6672299. DOI: 10.1523/JNEUROSCI.0445-06.2007. View

17.

Roth S, Li B, Rosenbaum P, Gupta H, Goldstein I, Maxwell K . Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci. 1998; 39(5):777-85. View

18.

Yang P, Peairs J, Tano R, Jaffe G . Oxidant-mediated Akt activation in human RPE cells. Invest Ophthalmol Vis Sci. 2006; 47(10):4598-606. DOI: 10.1167/iovs.06-0140. View

19.

Roth S, Dreixler J, Shaikh A, Lee K, Bindokas V . Mitochondrial potassium ATP channels and retinal ischemic preconditioning. Invest Ophthalmol Vis Sci. 2006; 47(5):2114-24. PMC: 2610248. DOI: 10.1167/iovs.05-1068. View

20.

Judge A, Sood V, Shaw J, Fang D, McClintock K, MacLachlan I . Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol. 2005; 23(4):457-62. DOI: 10.1038/nbt1081. View